Aveeno Baby Eczema Therapy Nighttime Balm

Aveeno is a globally recognized skincare brand that traces its heritage back to 1945 in the United States. Founded by brothers Albert and Sidney Musher, the brand pioneered the use of colloidal oatmeal to treat skin conditions, a scientific approach they termed 'Active Naturals.' This specific product, the Baby Eczema Therapy Nighttime Balm, is designed for sensitive infant skin, utilizing concentrated oatmeal and ceramides to provide relief from irritation.

Aveeno was acquired by the multinational conglomerate Johnson & Johnson in 1999. In 2023, Johnson & Johnson transitioned its consumer health division into a standalone company called Kenvue. As a result, Aveeno is now part of the Kenvue portfolio, which remains headquartered in the United States and manages various global personal care brands. Manufacturing for Aveeno products occurs in several locations worldwide, including the United States, Canada, and Korea, depending on the specific product line and regional distribution network.